Jane Street Group LLC grew its holdings in shares of Core Laboratories Inc. (NYSE:CLB – Free Report) by 54.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 111,353 shares of the oil and gas company’s stock after purchasing an additional 39,364 shares during the quarter. Jane Street Group LLC’s holdings in Core Laboratories were worth $1,928,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently made changes to their positions in CLB. Assetmark Inc. purchased a new stake in shares of Core Laboratories during the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC increased its position in shares of Core Laboratories by 173.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock valued at $35,000 after purchasing an additional 1,293 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in Core Laboratories by 2,688.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock worth $42,000 after acquiring an additional 2,339 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in Core Laboratories by 843.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company’s stock worth $57,000 after acquiring an additional 2,936 shares in the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new stake in Core Laboratories in the 4th quarter worth approximately $149,000. Hedge funds and other institutional investors own 97.81% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. Stifel Nicolaus reduced their target price on shares of Core Laboratories from $19.00 to $15.00 and set a “hold” rating for the company in a report on Tuesday, April 15th. Citigroup reduced their target price on shares of Core Laboratories from $16.00 to $13.00 and set a “neutral” rating for the company in a report on Tuesday, May 13th. Finally, StockNews.com lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a report on Friday, April 25th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $15.00.
Core Laboratories Trading Up 0.2%
Core Laboratories stock opened at $11.89 on Friday. The stock has a market cap of $557.35 million, a P/E ratio of 18.01, a PEG ratio of 0.99 and a beta of 1.45. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. Core Laboratories Inc. has a 1 year low of $10.14 and a 1 year high of $25.13. The firm’s 50 day moving average price is $13.01 and its 200-day moving average price is $16.46.
Core Laboratories (NYSE:CLB – Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.01). The company had revenue of $123.59 million for the quarter, compared to the consensus estimate of $125.09 million. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. The company’s quarterly revenue was down 4.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.19 EPS. On average, equities analysts predict that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.
Core Laboratories Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th will be given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Monday, May 5th. Core Laboratories’s payout ratio is currently 6.78%.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Read More
- Five stocks we like better than Core Laboratories
- Options Trading – Understanding Strike Price
- Top 4 ETFs for China Exposure After Tariff Relief
- What Are Treasury Bonds?
- Build a Complete Bond Portfolio With These 4 ETFs
- Most active stocks: Dollar volume vs share volume
- MarketBeat Week in Review – 05/12 – 05/16
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLB – Free Report).
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.